EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
Since Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company?s focused efforts to improve North American Health Care Services operations are delayed against previous assumptions. Therefore, Fresenius Medical Care now assumes lower contributions in the financial year 2022.
Consequently, Fresenius Medical Care now expects net income (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) for the financial year 2022 to decline in the high teens to mid-twenties percentage range. The Company continues to anticipate revenue to grow at a low-single digit percentage range in the financial year 2022. These targets are in constant currency and exclude special items.
Contact:Dr. Dominik Heger EVP | Head of Investor Relations, Strategic Development & Communications firstname.lastname@example.org P. +49 6172 609 2601
30-Oct-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.comLanguage: English Company: Fresenius Medical Care AG & Co. KGaA Else-Kr?ner-Stra?e 1 61352 Bad Homburg
Germany Phone: +49 (0) 6172- 609 2525 Fax: +49 (0) 6172- 609 2301 E-mail: email@example.com Internet: www.freseniusmedicalcare.com ISIN: DE0005785802 WKN: 578580 Indices: DAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange EQS News ID: 1475053 ? End of Announcement EQS News Service